Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA

Gurinder Singh, Amitesh Agarwal, Wei Zhang, Yong Fang Kuo, Rizwana Sultana, Gulshan Sharma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Growing evidence supports that patients with chronic obstructive pulmonary disease (COPD) and coexisting obstructive sleep apnea (OSA) have poor prognosis. This association is described as overlap syndrome. Positive airway pressure (PAP) therapy is now the preferred treatment for OSA. We hypothesized that use of PAP therapy in elderly patients with overlap syndrome would be associated with lower healthcare utilization. Methods: In this retrospective cohort study, we analyzed data from 5% national sample of fee-for-service Medicare beneficiaries with a diagnosis of COPD who were newly started on PAP therapy in 2011. We examined the effect of PAP therapy on emergency room (ER) visits and hospitalizations for all-cause and COPD-related conditions in the 1 year pre- and 1 year post-initiation of PAP therapy. Results: In year 2011, we identified 319 patients with overlap syndrome who were new users of PAP therapy. In this cohort of patients, hospitalization rates for COPD-related conditions were significantly lower in the 1 year post-initiation of PAP therapy compared to the 1-year pre-initiation period (19.4 vs 25.4%, P value = 0.03). However, ER visits (for any cause or COPD-related conditions) and hospitalization rates for any cause did not differ significantly in the pre- and post-initiation periods. PAP therapy was more beneficial in older adults, those with higher COPD complexity, and those with three or more comorbidities. Conclusion: Initiation of PAP therapy in elderly patients with overlap syndrome is associated with a reduction in hospitalization for COPD-related conditions, but not for all-cause hospitalizations and ER visits.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalSleep and Breathing
DOIs
StateAccepted/In press - Jun 22 2018

Fingerprint

Obstructive Sleep Apnea
Medicare
Chronic Obstructive Pulmonary Disease
Hospitalization
Pressure
Therapeutics
Hospital Emergency Service
Fee-for-Service Plans
Comorbidity
Cohort Studies
Retrospective Studies
Delivery of Health Care

Keywords

  • COPD
  • Hospitalization and healthcare utilization
  • OSA
  • Overlap syndrome
  • PAP

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Clinical Neurology

Cite this

Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA. / Singh, Gurinder; Agarwal, Amitesh; Zhang, Wei; Kuo, Yong Fang; Sultana, Rizwana; Sharma, Gulshan.

In: Sleep and Breathing, 22.06.2018, p. 1-8.

Research output: Contribution to journalArticle

@article{fa9e371bbff14496a9903aca112e31bb,
title = "Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA",
abstract = "Objective: Growing evidence supports that patients with chronic obstructive pulmonary disease (COPD) and coexisting obstructive sleep apnea (OSA) have poor prognosis. This association is described as overlap syndrome. Positive airway pressure (PAP) therapy is now the preferred treatment for OSA. We hypothesized that use of PAP therapy in elderly patients with overlap syndrome would be associated with lower healthcare utilization. Methods: In this retrospective cohort study, we analyzed data from 5{\%} national sample of fee-for-service Medicare beneficiaries with a diagnosis of COPD who were newly started on PAP therapy in 2011. We examined the effect of PAP therapy on emergency room (ER) visits and hospitalizations for all-cause and COPD-related conditions in the 1 year pre- and 1 year post-initiation of PAP therapy. Results: In year 2011, we identified 319 patients with overlap syndrome who were new users of PAP therapy. In this cohort of patients, hospitalization rates for COPD-related conditions were significantly lower in the 1 year post-initiation of PAP therapy compared to the 1-year pre-initiation period (19.4 vs 25.4{\%}, P value = 0.03). However, ER visits (for any cause or COPD-related conditions) and hospitalization rates for any cause did not differ significantly in the pre- and post-initiation periods. PAP therapy was more beneficial in older adults, those with higher COPD complexity, and those with three or more comorbidities. Conclusion: Initiation of PAP therapy in elderly patients with overlap syndrome is associated with a reduction in hospitalization for COPD-related conditions, but not for all-cause hospitalizations and ER visits.",
keywords = "COPD, Hospitalization and healthcare utilization, OSA, Overlap syndrome, PAP",
author = "Gurinder Singh and Amitesh Agarwal and Wei Zhang and Kuo, {Yong Fang} and Rizwana Sultana and Gulshan Sharma",
year = "2018",
month = "6",
day = "22",
doi = "10.1007/s11325-018-1680-0",
language = "English (US)",
pages = "1--8",
journal = "Sleep and Breathing",
issn = "1520-9512",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA

AU - Singh, Gurinder

AU - Agarwal, Amitesh

AU - Zhang, Wei

AU - Kuo, Yong Fang

AU - Sultana, Rizwana

AU - Sharma, Gulshan

PY - 2018/6/22

Y1 - 2018/6/22

N2 - Objective: Growing evidence supports that patients with chronic obstructive pulmonary disease (COPD) and coexisting obstructive sleep apnea (OSA) have poor prognosis. This association is described as overlap syndrome. Positive airway pressure (PAP) therapy is now the preferred treatment for OSA. We hypothesized that use of PAP therapy in elderly patients with overlap syndrome would be associated with lower healthcare utilization. Methods: In this retrospective cohort study, we analyzed data from 5% national sample of fee-for-service Medicare beneficiaries with a diagnosis of COPD who were newly started on PAP therapy in 2011. We examined the effect of PAP therapy on emergency room (ER) visits and hospitalizations for all-cause and COPD-related conditions in the 1 year pre- and 1 year post-initiation of PAP therapy. Results: In year 2011, we identified 319 patients with overlap syndrome who were new users of PAP therapy. In this cohort of patients, hospitalization rates for COPD-related conditions were significantly lower in the 1 year post-initiation of PAP therapy compared to the 1-year pre-initiation period (19.4 vs 25.4%, P value = 0.03). However, ER visits (for any cause or COPD-related conditions) and hospitalization rates for any cause did not differ significantly in the pre- and post-initiation periods. PAP therapy was more beneficial in older adults, those with higher COPD complexity, and those with three or more comorbidities. Conclusion: Initiation of PAP therapy in elderly patients with overlap syndrome is associated with a reduction in hospitalization for COPD-related conditions, but not for all-cause hospitalizations and ER visits.

AB - Objective: Growing evidence supports that patients with chronic obstructive pulmonary disease (COPD) and coexisting obstructive sleep apnea (OSA) have poor prognosis. This association is described as overlap syndrome. Positive airway pressure (PAP) therapy is now the preferred treatment for OSA. We hypothesized that use of PAP therapy in elderly patients with overlap syndrome would be associated with lower healthcare utilization. Methods: In this retrospective cohort study, we analyzed data from 5% national sample of fee-for-service Medicare beneficiaries with a diagnosis of COPD who were newly started on PAP therapy in 2011. We examined the effect of PAP therapy on emergency room (ER) visits and hospitalizations for all-cause and COPD-related conditions in the 1 year pre- and 1 year post-initiation of PAP therapy. Results: In year 2011, we identified 319 patients with overlap syndrome who were new users of PAP therapy. In this cohort of patients, hospitalization rates for COPD-related conditions were significantly lower in the 1 year post-initiation of PAP therapy compared to the 1-year pre-initiation period (19.4 vs 25.4%, P value = 0.03). However, ER visits (for any cause or COPD-related conditions) and hospitalization rates for any cause did not differ significantly in the pre- and post-initiation periods. PAP therapy was more beneficial in older adults, those with higher COPD complexity, and those with three or more comorbidities. Conclusion: Initiation of PAP therapy in elderly patients with overlap syndrome is associated with a reduction in hospitalization for COPD-related conditions, but not for all-cause hospitalizations and ER visits.

KW - COPD

KW - Hospitalization and healthcare utilization

KW - OSA

KW - Overlap syndrome

KW - PAP

UR - http://www.scopus.com/inward/record.url?scp=85048766655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048766655&partnerID=8YFLogxK

U2 - 10.1007/s11325-018-1680-0

DO - 10.1007/s11325-018-1680-0

M3 - Article

SP - 1

EP - 8

JO - Sleep and Breathing

JF - Sleep and Breathing

SN - 1520-9512

ER -